Suresh Ramalingham: The Role of PARP Inhibitors in Lung Cancer Treatment
Description: Dr. Suresh Ramalingham talks about the potential role of PARP inhibitors in lung cancer treatment for both non-small cell and small cell lung cancer at the 2012 Multidisciplinary Symposium in Thoracic Oncology in Chicago.
Suresh Ramalingham, MD is Professor, Chief of Thoracic Oncology and Director of Medical Oncology at Emory University in Atlanta, Georgia. Dr. Ramalingam specializes in the treatment of lung cancer and leads a group of physicians, scientists and care providers at Emory, whose collective goals and aspirations are to improve the outcomes for every patient with lung cancer.
Shared By : vitaloptions
Posted on : 10/20/12
Added : 4 years ago